Morgan Stanley
CNXU

Morgan Stanley’s Conexeu Sciences Inc CNXU Stock Holding History

Morgan Stanley’s Portfolio CNXU Stock Details CNXU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$64.1K Buy
+5,871
New +$75.5K ﹤0.01% 6417

Other funds holding CNXU

UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $1.54B AUM 30.1% 1-Year Est. Return
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $80B AUM 26.12% 1-Year Est. Return
IWC
Integrated Wealth Concepts Waltham, Massachusetts $20.5B AUM 24.45% 1-Year Est. Return

Morgan Stanley's CNXU Position: Q2 2026 in Review

Morgan Stanley opened a new position in Conexeu Sciences Inc (CNXU) in Q2 2026: 5,871 shares worth $64.1K. The stake represents ﹤0.01% of the portfolio and ranks #6417 among its holdings.

6 funds tracked by Wall St. Rank hold CNXU as of Q2 2026.

  • Morgan Stanley held 5,871 shares of Conexeu Sciences Inc worth $64.1K as of Q2 2026.
  • Conexeu Sciences Inc was a new Morgan Stanley position in Q2 2026.
  • Conexeu Sciences Inc made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #6417 holding.
  • 6 funds tracked by Wall St. Rank held Conexeu Sciences Inc as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.